Aziyo biologics announces product design completion for its next generation cangaroo® envelope for implantable electronic devices

Silver spring, md., feb. 11, 2021 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today product design completion for cangaroo® with antibiotics, the next generation of the company's cangaroo envelope.
AZYO Ratings Summary
AZYO Quant Ranking